Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
44.60
+0.43 (0.96%)
Real-time:   12:11PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 44.25 - 44.79
52 week 29.47 - 45.17
Open 44.45
Vol / Avg. 4.09M/16.40M
Mkt cap 135.64B
P/E 20.39
Div/yield 0.42/3.77
EPS 2.19
Shares 3.04B
Beta     -
Inst. own 75%
Jul 27, 2012
Q2 2012 Merck & Co., Inc. Earnings Conference Call - Webcast
Jul 27, 2012
Q2 2012 Merck & Co., Inc. Earnings Release
Jun 19, 2012
Merck & Co., Inc. at Wells Fargo Health Care Conference - Webcast
Jun 13, 2012
Merck & Co., Inc Webcast on Suvorexant Phase III Data - Webcast
Jun 4, 2012
Merck & Co., Inc. at Jefferies Global Healthcare Conference - Webcast
May 31, 2012
Merck & Co., Inc. at Sanford C. Bernstein & Co. Strategic Decisions Conference - Webcast
May 22, 2012
Merck & Co., Inc. Annual Shareholder Meeting
May 17, 2012
Merck & Co., Inc. at Bank of America Merrill Lynch Health Care Conference - Webcast
May 9, 2012
Merck & Co., Inc. at Deutsche Bank AG Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 14.78% 13.30%
Operating margin 21.77% 15.26%
EBITD margin - 32.21%
Return on average assets - 6.06%
Return on average equity - 11.49%
Employees 84,000 -
Carbon Disclosure Rating - 79/100

Address

One Merck Drive, P.O. Box 100
WHITEHOUSE STATION, NJ 08889-0100
United States - Map
+1-908-4231000 (Phone)
+1-908-2987082 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia
Discussion Group - Google Finance

Description

Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company�s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. In May 2011, it acquired Inspire Pharmaceuticals, Inc. In September 2011, the Company sold its 50% interest in the Johnson & Johnson�Merck Consumer Pharmaceuticals Company joint venture. In December 2011, the Company established an Asia Research & Development (R&D) headquarters for drug discovery and development located in Beijing, China.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation - Reuters
Peter N. Kellogg Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation - Reuters
J. Chris Scalet Executive Vice President - Global Services, Chief Information Officer
Age: 53
Bio & Compensation - Reuters
Bruce N. Kuhlik Executive Vice President, General Counsel
Age: 55
Bio & Compensation - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 57
Bio & Compensation - Reuters
Willie A. Deese Executive Vice President, President - Merck Manufacturing Division
Age: 56
Bio & Compensation - Reuters
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 49
Bio & Compensation - Reuters
Cuong Viet Do Executive Vice President, Chief Strategy Officer
Age: 45
Bio & Compensation - Reuters
Bridgette P. Heller Executive Vice President, President - Merck Consumer Care
Age: 50
Bio & Compensation - Reuters
Peter S. Kim Ph.D. Executive Vice President, President - Merck Research Laboratories
Age: 53
Bio & Compensation - Reuters